Evidence map›Paper›PMID 26569202›Full record

ArticleMolecules (Basel, Switzerland)2015

Synthesis of Novel β-Keto-Enol Derivatives Tethered Pyrazole, Pyridine and Furan as New Potential Antifungal and Anti-Breast Cancer Agents.

Smaail Radi, Said Tighadouini, Olivier Feron, Olivier Riant, Mohammed Bouakka, Redouane Benabbes, Yahia N Mabkhot

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Smaail RadiDepartment of Chemistry, Faculty of Sciences, University Mohamed I, Oujda-60000, Morocco. radi_smaail@yahoo.fr.
Said TighadouiniDepartment of Chemistry, Faculty of Sciences, University Mohamed I, Oujda-60000, Morocco. tighadouinis@gmail.com.
Olivier FeronAngiogenesis and Cancer Research Lab, Pole of Pharmacology and Therapeutics-FATH5349, Institute of Experimental and Clinical Research, Université catholique de Louvain (UCL), Brussels 1200, Belgium. olivier.feron@uclouvain.be.
Olivier RiantMolecules, Solids and Reactivity (MOST), Institute of Condensed Mater and Nanosciences (IMCN), Université catholique de Louvain (UCL), Place Louis Pasteur 1, Louvain-la-Neuve 1348, Belgium. olivier.riant@uclouvain.be.
Mohammed BouakkaDepartment of Biologie, Faculty of Sciences, University Mohamed I, Oujda-60000, Morocco. bouakkam@yahoo.fr.
Redouane BenabbesDepartment of Biologie, Faculty of Sciences, University Mohamed I, Oujda-60000, Morocco. red.bes72@gmail.com.
Yahia N MabkhotDepartment of Chemistry, Faculty of Science, King Saud University, P. O. Box 2455, Riyadh 11451, Saudi Arabia. yahia@ksu.edu.sa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, a new generation of highly promising inhibitors bearing β-keto-enol functionality has emerged. Reported herein is the first synthesis and use of novel designed drugs based on the β-keto-enol group embedded with heterocyclic moieties such as pyrazole, pyridine, and furan, prepared in a one-step procedure by mixed Claisen condensation. All the newly synthesized compounds were characterized by FT-IR, ¹H-NMR, (13)C-NMR, ESI/LC-MS, elemental analysis, and evaluated for their in vitro antiproliferative activity against breast cancer (MDA-MB241) human cell lines and fungal strains (Fusarium oxysporum f.sp albedinis FAO). Three of the synthesized compounds showed potent activity against fungal strains with IC50 values in the range of 0.055-0.092 µM. The results revealed that these compounds showed better IC50 values while compared with positive controls.

Indexed as

Antifungal AgentsAntineoplastic AgentsCell Line, TumorFemaleFungiFuransHumansInhibitory Concentration 50Microbial Sensitivity TestsMolecular StructureNuclear Magnetic Resonance, BiomolecularPyrazolesPyridinesAntifungal AgentsAntineoplastic AgentsfuranFuranspyrazolePyrazolespyridinePyridinesbreast cancerfungal strainsheterocyclesketo-enols

Identifiers

PMID26569202
PMCPMC6332371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.